Search

Your search keyword '"Tomassetti S"' showing total 360 results

Search Constraints

Start Over You searched for: Author "Tomassetti S" Remove constraint Author: "Tomassetti S"
360 results on '"Tomassetti S"'

Search Results

1. The Role of the Multidisciplinary Health Care Team in the Management of Patients with Systemic Sclerosis

4. Using Imaging to Predict, Identify, and Monitor Progression of Interstitial Lung Disease: Consensus Findings From a Modified Delphi Study

5. How Should Patients With Progressive Pulmonary Fibrosis Be Identified? Consensus Findings From a Modified Delphi Study

7. Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

9. Successful Use of Monoclonal and Antiviral Therapy in Immunocompromised Patients With Persistent and/or Relapsing COVID-19

15. Phenotypes of post covid interstitial lung disease; clinical, radiological, and pathological correlations.

18. Role of BAL in COVID-19 patients: a prospective multicentre study

20. Clinical course of IPF in Italian patients during 12 months of observation: results from the FIBRONET observational study

22. Clinical course of IPF in Italian patients during 12 months of observation: results from the FIBRONET observational study

24. The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19

25. Lung Cancer in Patients with Idiopathic Pulmonary Fibrosis: A Retrospective Multicenter Study in Europe

28. Effet du nintédanib sur le déclin de la capacité vitale forcée (CVF) chez les patients atteints de pneumopathies interstitielles diffuses (PID) chroniques fibrosantes progressives en fonction du délai écoulé depuis le diagnostic de PID

29. Phase 2 KEYNOTE‐B68 study: pembrolizumab every 6 weeks in relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL) or primary mediastinal B‐cell lymphoma (PMBCL).

32. POS1228 THE ROLE OF CHEST CT IN UNDERSTANDING INTERSTITIAL LUNG DISEASE (ILD): SYSTEMIC SCLEROSIS (SSc). VERSUS COVID-19

33. A Multidisciplinary Multicenter Study Evaluating Risk Factors, Prevalence and Characteristics of Post-COVID-19 Interstitial Lung Syndrome PCOILS

35. Detection and Early Referral of Patients With Interstitial Lung Abnormalities: An Expert Survey Initiative

36. consensus recommendations, and research priorities

37. Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities

38. Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities

39. Progressive fibrosing interstitial lung disease: clinical uncertainties, consensus recommendations, and research priorities

40. Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

42. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study

44. Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

46. Resequencing study confirms that host defense and cell senescence gene variants contribute to the risk of idiopathic pulmonary fibrosis

47. The prognostic role of Gender-Age-Physiology system in idiopathic pulmonary fibrosis patients treated with pirfenidone

48. Pirfenidone in real life: A retrospective observational multicentre study in Italian patients with idiopathic pulmonary fibrosis

49. Diagnostic likelihood thresholds that define a working diagnosis of idiopathic pulmonary fibrosis

50. Correspondence

Catalog

Books, media, physical & digital resources